Correlation Between Mineralys Therapeutics, and Nurix Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Nurix Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Nurix Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Nurix Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Mineralys and Nurix is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Nurix Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Nurix Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 2.59 times less return on investment than Nurix Therapeutics. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.18 times less risky than Nurix Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 526.00 in Nurix Therapeutics on August 25, 2024 and sell it today you would earn a total of 1,679 from holding Nurix Therapeutics or generate 319.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Nurix Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Nurix Therapeutics |
Mineralys Therapeutics, and Nurix Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Nurix Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. RenovoRx | Mineralys Therapeutics, vs. Scpharmaceuticals |
| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |